Cetera Investment Advisers’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.87M Sell
186,605
-18,137
-9% -$571K 0.01% 1403
2025
Q4
$6.03M Buy
204,742
+19,356
+10% +$538K 0.01% 1332
2025
Q3
$4.68M Buy
185,386
+139,432
+303% +$3.4M 0.01% 1452
2025
Q2
$1.1M Buy
45,954
+4,308
+10% +$99.9K ﹤0.01% 2296
2025
Q1
$954K Buy
41,646
+8,985
+28% +$217K ﹤0.01% 2294
2024
Q4
$827K Buy
32,661
+24,006
+277% +$608K ﹤0.01% 2295
2024
Q3
$216K Sell
8,655
-2,877
-25% -$85.2K ﹤0.01% 3330
2024
Q2
$342K Buy
11,532
+1,337
+13% +$37.1K ﹤0.01% 2917
2024
Q1
$307K Buy
+10,195
New +$283K ﹤0.01% 3018
2023
Q4
Sell
-6,610
Closed -$245K 2339
2023
Q3
$245K Buy
6,610
+429
+7% +$16.4K ﹤0.01% 1859
2023
Q2
$241K Buy
+6,181
New +$242K ﹤0.01% 1876

Other funds holding RTO

Cetera Investment Advisers's RTO Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Rentokil (RTO) stake by 8.9% in Q1 2026, selling an estimated $571K and leaving 186,605 shares worth $5.87M. The position accounts for 0.01% of the portfolio, ranked #1403.

Cetera Investment Advisers first reported a position in RTO in Q2 2023 and has held it in 11 quarters since. The position peaked at $6.03M in Q4 2025. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Cetera Investment Advisers held 186,605 shares of Rentokil worth $5.87M as of Q1 2026.
  • Cetera Investment Advisers sold 18,137 Rentokil shares in Q1 2026, an estimated $571K.
  • Rentokil made up 0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #1403 holding.
  • Cetera Investment Advisers first reported a position in Rentokil in Q2 2023 and has held it in 11 quarters since.
  • Cetera Investment Advisers's Rentokil position peaked at $6.03M in Q4 2025.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.